Prescription Coverage in a Changing Policy Landscape
Session Overview This session will explore recent policy changes and announcements affecting GLP-1 therapies and emerging prescription drug initiatives, including TrumpRx. Our speaker will examine how these developments may influence insurance coverage, patient access, and prescribing considerations. The discussion will place these changes in the broader context of evolving coverage and affordability pressures, highlighting potential...
